Abstract

BackgroundInflammation plays a key role in the development of atherosclerosis and in the pathogenesis of acute coronary syndrome (ACS). Leukocytes and leukocytes ratios were recognized as inflammatory markers in predicting the presence and severity of ACS.MethodsThis study aimed to investigate the diagnostic accuracy of neutrophil to lymphocyte ratio (NLR) and monocyte to lymphocyte ratio (MLR) with ACS. One hundred patients admitted to the Cardiac Center who were confirmed to have ACS and 100 healthy controls confirmed not to have ACS were enrolled in this study. ECG and troponin I test were used as gold standards to make sure that the participants with or without ACS. Total white blood cells (WBCs) count, NLR, and MLR values were estimated.ResultsTotal WBCs, neutrophil, and monocyte counts were significantly higher while lymphocyte counts were significantly lower in ACS patients than in the healthy controls (p < 0.001). NLR and MLR were significantly higher in ACS patients than in the healthy controls (p < 0.001). Among all the studied markers, NLR was found to be the strongest predictive marker of ACS (OR: 3.3, p < 0.001), whereas MLR was non-significant (p > 0.05). A cut-off value of 2.9 of NLR had 90% sensitivity and 88% specificity while 0.375 cut-off value of MLR had 79% sensitivity, 91% specificity for predicting ACS presence.ConclusionsNLR is a simple, widely available, and inexpensive inflammatory marker which can be an auxiliary biomarker in the diagnosis of ACS with a cut-off value of 2.9 in our population.

Highlights

  • Inflammation plays a key role in the development of atherosclerosis and in the pathogenesis of acute coronary syndrome (ACS)

  • Total Total white blood cells (WBC), neutrophil, and monocytes counts, were significantly higher while lymphocytes count was significantly lower in ACS patients than in the healthy controls (p < 0.001)

  • neutrophil to lymphocyte ratio (NLR) and monocyte to lymphocyte ratio (MLR) were significantly higher in the ACS patients than in the healthy controls (p < 0.001)

Read more

Summary

Introduction

Inflammation plays a key role in the development of atherosclerosis and in the pathogenesis of acute coronary syndrome (ACS). Leukocytes and leukocytes ratios were recognized as inflammatory markers in predicting the presence and severity of ACS. Cardiovascular diseases (CVD) remain the major cause of death worldwide. Inflammation plays a key role in the development of atherosclerosis and in the pathogenesis of ACS. To show this inflammation, numerous markers such as hsCRP, fibrinogen, and interleukins have been used used [2, 3]. Leukocytes and its subtypes were studied as an inflammatory marker in predicting adverse events in ACS patients [4,5,6]. The systemic immune-inflammation index was independent predictor of the no-reflow phenomenon in patients with ACS [7]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.